» Articles » PMID: 15986138

Protein Kinase C in Melanoma

Overview
Specialty Oncology
Date 2005 Jun 30
PMID 15986138
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase C (PKC) is activated by diacylglycerol generated by receptor-mediated hydrolysis of membrane phospholipids to mediate signals for cell growth and plays as a target of tumor-promoting phorbol esters in malignant transformation. PKC is a family of enzymes and their expression profiles have been examined in the normal melanocytes and melanoma cells, and studies have been carried out on the functions of PKC isoforms in proliferation, transformation, and metastasis of melanoma cells. Here, we summarize current knowledge of the expression and possible roles of the PKC family in melanoma in comparison with those of normal melanocytes.

Citing Articles

Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling.

Yadav V, Jobe N, Satapathy S, Mohapatra P, Andersson T Cancers (Basel). 2022; 14(24).

PMID: 36551563 PMC: 9775662. DOI: 10.3390/cancers14246077.


Analysis of protein kinase C (HcPKC) gene expression and single-nucleotide polymorphisms related to inner shell color traits in Hyriopsis cumingii.

Zhang M, Chen X, Zhang J, Guo B, Li J, Bai Z BMC Genom Data. 2022; 23(1):71.

PMID: 36085015 PMC: 9463788. DOI: 10.1186/s12863-022-01085-3.


The Role of Calcium Signaling in Melanoma.

Zhang H, Chen Z, Zhang A, Gupte A, Hamilton D Int J Mol Sci. 2022; 23(3).

PMID: 35162934 PMC: 8835635. DOI: 10.3390/ijms23031010.


The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.

Mohammed F, Stones D, Zarling A, Willcox C, Shabanowitz J, Cummings K Oncotarget. 2017; 8(33):54160-54172.

PMID: 28903331 PMC: 5589570. DOI: 10.18632/oncotarget.16952.


Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis.

Zhou P, Qin J, Li Y, Li G, Wang Y, Zhang N J Exp Clin Cancer Res. 2017; 36(1):115.

PMID: 28865485 PMC: 5581453. DOI: 10.1186/s13046-017-0585-2.